Javascript must be enabled to continue!
Cytotoxicity of arginine deprivation to AML cells is mediated by autophagy / by Fatima Taki . (c2020)
View through CrossRef
In this study, we assess the activation of autophagy in AML cells following arginine deprivation, the mechanism of its activation, and its impact on cell cytotoxicity. Arginine deprivation was induced using a pegylated recombinant human Arginase I [HuArgI(Co)-PEG5000], in which the two Mn2+ ions of the active site have been replaced with Co2+ ions. AML cell lines were tested, and activation of autophagy was determined by staining for autophagosomes on flow cytometry. The impact of autophagy on cell cytotoxicity of arginine deprivation was assessed through inhibition of autophagy using the downstream autophagy inhibitor chloroquine (CQ). [HuArgI(Co)-PEG5000]-induced arginine deprivation led to significant and sustained activation of autophagy starting at 24 hours and lasting up to 120 hours following arginine deprivation in all cell lines. Inhibition of autophagy, using chloroquine, led to a significant decrease in cell cytotoxicity evident at 48 hours and up to 120 hours. This indicates that activation of autophagy in response to arginine deprivation, is leading to AML cell death (death by autophagy). This was further confirmed by the fact that cell death observed following arginine deprivation in AML cells was caspase-independent and nonapoptotic. Moreover, AML cells were shown to overexpress the major key player in the biosynthesis of L-arginine; Argininosuccinate Synthetase-1 (ASS-1) upon arginine deprivation without it conferring resistance to death by autophagy induced by HuArgI(Co)-PEG5000. Addition of the ROS scavenger N-acetyl-cysteine (NAC) repressed the autophagic response and reversed cytotoxicity of arginine deprivation to AML cells, indicating that the activation of autophagy is induced following ROS generation. Finally, our study demonstrates that in AML cells, arginine deprivation induces autophagy activation leading to cell death irrespective the overexpression of ASS-1. We have also shown that the activation of autophagy and the subsequent death by autophagy of AML cells is induced through generation of ROS.
Title: Cytotoxicity of arginine deprivation to AML cells is mediated by autophagy / by Fatima Taki . (c2020)
Description:
In this study, we assess the activation of autophagy in AML cells following arginine deprivation, the mechanism of its activation, and its impact on cell cytotoxicity.
Arginine deprivation was induced using a pegylated recombinant human Arginase I [HuArgI(Co)-PEG5000], in which the two Mn2+ ions of the active site have been replaced with Co2+ ions.
AML cell lines were tested, and activation of autophagy was determined by staining for autophagosomes on flow cytometry.
The impact of autophagy on cell cytotoxicity of arginine deprivation was assessed through inhibition of autophagy using the downstream autophagy inhibitor chloroquine (CQ).
[HuArgI(Co)-PEG5000]-induced arginine deprivation led to significant and sustained activation of autophagy starting at 24 hours and lasting up to 120 hours following arginine deprivation in all cell lines.
Inhibition of autophagy, using chloroquine, led to a significant decrease in cell cytotoxicity evident at 48 hours and up to 120 hours.
This indicates that activation of autophagy in response to arginine deprivation, is leading to AML cell death (death by autophagy).
This was further confirmed by the fact that cell death observed following arginine deprivation in AML cells was caspase-independent and nonapoptotic.
Moreover, AML cells were shown to overexpress the major key player in the biosynthesis of L-arginine; Argininosuccinate Synthetase-1 (ASS-1) upon arginine deprivation without it conferring resistance to death by autophagy induced by HuArgI(Co)-PEG5000.
Addition of the ROS scavenger N-acetyl-cysteine (NAC) repressed the autophagic response and reversed cytotoxicity of arginine deprivation to AML cells, indicating that the activation of autophagy is induced following ROS generation.
Finally, our study demonstrates that in AML cells, arginine deprivation induces autophagy activation leading to cell death irrespective the overexpression of ASS-1.
We have also shown that the activation of autophagy and the subsequent death by autophagy of AML cells is induced through generation of ROS.
Related Results
Targeting Autophagy As a Therapeutic Strategy in Acute Myeloid Leukemia
Targeting Autophagy As a Therapeutic Strategy in Acute Myeloid Leukemia
Abstract
Introduction: Autophagy is a process whereby cells digest their own organelles in conditions of stress, such as low nutrient concentration, hypoxia or expos...
Human Recombinant Arginase I (Co)-PEG5000-Induced Arginine Depletion of Breast Cancer Cell Lines Causes Autophagy Mediated Cell Death
Human Recombinant Arginase I (Co)-PEG5000-Induced Arginine Depletion of Breast Cancer Cell Lines Causes Autophagy Mediated Cell Death
In this study, we showed for the first time that arginine deprivation induced by a recombinant human arginase drug induces selective cytotoxicity mediated by autophagy in distinct ...
Categorizing Molecular Mutations in MDS and AML
Categorizing Molecular Mutations in MDS and AML
Abstract
Introduction:
A huge amount of data on genetic alterations has been compiled by high throughput sequencing studies in several hematologic mal...
Down-Regulation of Signal Transducer and Activator of Transcription 3 Enhances Acute Myeloid Leukemia-Derived Dendritic Cell Function
Down-Regulation of Signal Transducer and Activator of Transcription 3 Enhances Acute Myeloid Leukemia-Derived Dendritic Cell Function
Abstract
Abstract 3140
Immunotherapies, including stimulating patients' immune system with acute myeloid leukemia (AML)-derived dendritic cell (DC) va...
Low miR‐34c expression is associated with poor outcome in de novo acute myeloid leukemia
Low miR‐34c expression is associated with poor outcome in de novo acute myeloid leukemia
SummaryIntroductionMicroRNA‐34c (miR‐34c) has been found to play important roles in tumorigenesis. However, little is known about miR‐34c expression and the impact on prognosis in ...
Clinical and Molecular Characteristics of NPM1MTDe Novo AML ( NPM1MT dnAML) Differ from NPM1MT therapy-associated AML ( NPM1MT tAML)
Clinical and Molecular Characteristics of NPM1MTDe Novo AML ( NPM1MT dnAML) Differ from NPM1MT therapy-associated AML ( NPM1MT tAML)
Background: NPM1-mutated AML accounts for 30% of all adult AML cases and frequently carries a favorable prognostic impact when enriched by a normal karyotype and the absence of FLT...
Abstract 1674: Inhibition of GSK3 reduces p70S6K activity and promotes autophagy independently of the JNK-cJun pathway.
Abstract 1674: Inhibition of GSK3 reduces p70S6K activity and promotes autophagy independently of the JNK-cJun pathway.
Abstract
Considering that a tumor promoting role for GSK3 has been suggested in pancreatic cancer (PC) cells and that GSK3 inhibitors are currently under clinical tr...
Abstract 6869: Paired single-cell B-cell transcriptomics and receptor sequencing reveal activation states and clonal signatures that characterize B cell immunity in acute myeloid leukemia
Abstract 6869: Paired single-cell B-cell transcriptomics and receptor sequencing reveal activation states and clonal signatures that characterize B cell immunity in acute myeloid leukemia
Abstract
Acute myeloid leukemia (AML) is the second most common adult leukemia with a five-year survival rate around 30%. For decades, AML treatment has centered aro...


